Biblio
External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy. Leukemia. 2023.
. Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. Am J Hematol. 2023.
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era. Ann Hematol. 2023.
. Validation of the imatinib-therapy failure model. Leukemia. 2023.